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Telomerase RNAReactivation of telomerase in endothelial cells (ECs) may be an effective approach to the treatment of
vascular disorders associated with telomere attrition and EC senescence. However, overexpression of human
telomerase reverse transcriptase (hTERT) does not prevent net telomere loss in ECs grown in standard
culture medium with exposure to atmospheric oxygen (21% O2). Since these culture conditions are hyperoxic
relative to normal tissue in vivo, where oxygen tension is estimated to be 1%–6%, we examined the effects of
reduced exposure to oxidative stress (OS) on telomere length maintenance in hTERT-transduced bone
marrow endothelial (BMhTERT) cells. Propagation of BMhTERT cells in the free radical scavenger, tert-
butylhydroxylamine (tBN), and/or in 5% O2 increased telomerase enzyme activity and facilitated telomere
length maintenance. The enhancement of telomerase activity correlated with higher levels of the telomerase
RNA component (hTR). We also investigated the role of the telomere binding protein, TRF1, in telomere
length regulation under alternate OS conditions. Inhibition of TRF1 function had no effect on telomere length
in BMhTERT cells grown under standard culture conditions. However, alleviation of OS by growth in tBN plus
5% O2, elevated hTR levels, enhanced telomerase enzyme activity, and enabled progressive telomere
lengthening. The direct impact of hTR levels on telomerase-mediated telomere lengthening was
demonstrated by overexpression of hTR. BMhTERT cells transduced with hTR exhibited very high telomerase
enzyme activity and underwent dramatic telomere lengthening under standard culture conditions. Overall,
these results demonstrate that hTR levels are reduced by mild hyperoxia and limit telomerase-mediated
telomere lengthening in hTERT-transduced ECs.row endothelial cells; di-LDL, diacetylated low-density l
e; hTR, human telomerase RNA component; NAC, N-ac
itative telomeric repeat ampliﬁcation protocol; ROS, reac
ustralia for Medical Research, PO Box 81, Randwick, NSW
lveas@ccia.unsw.edu.au (L.A. Veas), cykan@nsccahs.heal
Wen), a.james@victorchang.edu.au (A. James), Tracey.OBri
ute, 214 Hawkesbury Rd, Westmead, NSW 2145, Austra
ch, Royal North Shore Hospital, Paciﬁc Highway, St Leon
za Street, Newtown, NSW 2042, Australia.
lfred Hospital, Missenden Rd, Camperdown, NSW 2050
titute, 405 Liverpool St, Darlinghurst, NSW 2010, Austra
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Substantial evidence indicates that the replicative exhaustion of
endothelial cells (ECs) and the functional alterations that occur during
senescence contribute to the development of age-associated vascular
disorders, suchas atherosclerosis and chronic ischemic heart disease [1–
6]. As in other normal somatic cells, the onset of replicative senescencein cultured human ECs and in vascular cells in vivo is attributed (at least
in part) to the gradual erosion of telomeres [4,7–10]. Telomere
shortening occurs with consecutive cell division as a consequence of
the inability of DNA polymerases to replicate the 5′ terminus of linear
DNA (reviewed in Hug and Lingner [11]). Progressive telomere
shortening has been demonstrated in serially passaged cultures of ECs
and in arterial ECs in vivo in association with increasing age [7,8,12,13].ipoprotein; ECs, endothelial cells; EV, empty vector; FCS, fetal calf
etylcysteine; OS, oxidative stress; PD, population doubling; PSG,
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in primary human ﬁbroblasts and ECs exposed to oxidizing agents
[14–16]. Indeed, in vitro culture in standard medium and the
supraphysiological levels of oxygen present in the atmosphere
(~21%) generate sufﬁcient oxidative stress (OS) to accelerate
telomere erosion in normal ﬁbroblasts [17–19]. Accumulating
evidence suggests that OS contributes to age-dependent telomere
shortening in ECs, as well as the excessive telomere attrition
observed in ECs at sites of hemodynamic stress and/or from patients
at risk of coronary artery disease [7,8,16,20,21]. Telomere loss
observed under oxidative conditions is in part due to the exquisite
sensitivity of G-rich telomeric DNA to hydroxylation and single-
strand breaks [19,22,23].
In contrast to the telomere shortening observed in ECs and other
normal somatic cells, telomeres are maintained or elongated in 80%–
90% of cancer cells through the catalytic activity of telomerase [24].
Telomerase activity is very low or undetectable in most somatic cells,
with the exception of stem and progenitor cells, including endothelial
progenitor cells, which express telomerase at moderate levels.
Telomerase activity is downregulated during differentiation [25].
Using a highly sensitive PCR-based assay, very low levels of
telomerase activity (relative to tumor cells) have been detected in
early-passage mature ECs; however, this was shown to be rapidly
extinguished upon propagation [12,26,27].
Telomerase is a ribonuclear protein that includes a reverse
transcriptase (hTERT) as a catalytic core, an RNA component (hTR)
that serves as a substrate for synthesis of telomeric repeats and the
RNA binding and modifying protein, dyskerin [28]. Telomerase-
mediated telomere lengthening is regulated by the secondary
structure of the telomere, which is folded into a t-loop conformation
that conceals the single-stranded 3′ end [29] (reviewed in de Lange
[30]). The t-loop structure is maintained by a complex of telomere-
binding proteins, which includes TRF1 [31,32]. TRF1 binds as a
homodimer to double-stranded telomeric DNA through its Myb
binding domain and tethers other telomere binding proteins to the
shelterin complex [32,33]. TRF1 has been shown to function as a
negative regulator of telomere length in tumor cells, presumably by
securing the telomere in a secondary structure that is inaccessible to
telomerase [34].
Overexpression of hTERT reconstitutes telomerase activity and
confers normal human ECs with an extended replicative life span and
properties of phenotypically young cells [12,26,35–37]. The activation
of telomerase has therefore been proposed as a potential means for
rejuvenating ECs for therapeutic application in age-associated
vascular disorders [36,37]. However, unlike normal ﬁbroblasts and
epithelial cells that exhibit telomere length maintenance or extension
following reconstitution of telomerase [38–40], our group and
another have shown that, under standard culture conditions, hTERT
transduction and reconstitution of telomerase did not prevent net
telomere loss in normal human ECs derived from bone marrow,
dermis, and umbilical vein [12,26]. Clonal analyses of hTERT-
transduced bone marrow ECs (BMECs) revealed dramatic ﬂuctuations
in telomere length, with transient periods of telomere loss or net
telomere loss as the cells proliferated beyond senescence. Telomeres
were eventually stabilized at a very short mean length (~3 kbp) in
most immortalized BMEC cultures [41].
The current investigations aimed to determine whether inefﬁcient
telomere length maintenance in hTERT-transduced BMECs (BMhTERT
cells) was a consequence of exposure to OS. The results show that
chronic exposure to mild OS, inﬂicted by propagation under standard
culture conditions and atmospheric oxygen (21%), dampened telo-
merase enzyme activity and impeded telomere length maintenance
despite the constitutive overexpression of hTERT. Furthermore, it was
shown that telomerase enzyme activity and telomere maintenance
were restricted by limiting amounts of hTR when the cells were
cultured under these mildly hyperoxic conditions.2. Materials and methods
2.1. Cell culture
The establishment of BMhTERT cell lines was previously described
[12,41]. BMhTERT(2A2) and BMhTERT(2A10) are hTERT-transduced
BMEC clones that were established by limiting dilution of the
BMhTERT-1 mass culture [41]. BMhTERT-2 was established as an
independently transduced mass culture [12]. BMECs immortalized
with hTERT were previously shown to express EC markers, including
VEGFR-1, VEGFR-2, CD31, and von Willibrand factor VIII. They also
have capacity for uptake of diacetylated low-density lipoprotein (di-
LDL) [12].
Parental BMECs, BMhTERT-2, BMhTERT(2A2), and BMhTERT
(2A10) cells were grown in EC growth medium, which was composed
of M199 base medium (Invitrogen, Carlsbad, CA) supplemented with
20% fetal calf serum (FCS; ThermoTrace, Noble Park, Australia), 5%
human serum (Sigma, St Louis, MO), heparin (Pharmacia, Rydalmere,
Australia), ﬁbroblast growth factor β (Sigma), EC growth factor
(Roche Mannheim, Germany), and penicillin, streptomycin, and
glutamine (PSG; Invitrogen). To assess the effects of alleviating OS,
the medium was supplemented with 0.1 mM of the free radical
scavenger tert-butylhydroxylamine (tBN; Sigma) [42] and/or the cells
were cultured in 5% O2 in a PRO OXmodel 110 C chamber ﬁtted with a
PRO OX oxygen controller (BioSpherix, Lacona, NY). PDs were
calculated using the formula: PD=[log (expansion)/log 2], where
expansion was the number of cells harvested divided by the initial
number of cells seeded. Normal parental BMECs senesced at
approximately 35 PDs under control culture conditions [12].
2.2. Detection of reactive oxygen species (ROS)
BMhTERT-2 cells (1×105) were incubated in 3 μM of DHR123
(Sigma) for 20 min at 37 °C and then washed twice in phosphate-
buffered saline (PBS; Invitrogen). The cellswereharvestedwith trypsin–
EDTA (Invitrogen) and subsequently washed twice in cold PBS before
analysis on aﬂow cytometer (FACSCabilur; BDBiosciences, San Jose, CA)
usingCell Quest Software (BDBiosciences). Theﬂuorescence of oxidized
DHR123 was measured with an excitation wavelength of 514 nm and
emission wavelength of 680 nm. DH123 ﬂuorescence was corrected for
autoﬂuorescence by subtracting the geometric mean ﬂuorescence
intensity of unstained cells from the geometric mean ﬂuorescence
intensity of the stained sample. The corrected values for DH123
ﬂuorescence are expressed as means±standard error of the mean
(SEM) calculated from three assays.
2.3. Telomeric restriction fragment length (TRF) assay
Genomic DNA was prepared using a standard phenol/chloroform/
isoamyl alcohol procedure with Phase Lock Gel heavy tubes
(Eppendorf, Hamburg, Germany) and precipitated with 0.3 M sodium
acetate and two volumes of 100% ethanol. The integrity of the DNA
was examined on ethidium bromide-stained agarose gels. After
conﬁrming that there was no degradation, the DNA was digested
with 10 U each of Hinf1 and Rsa1 restriction enzymes (New England
Biolabs, Ipswich, MA). The TRF assay was performed using the Telo-
TAGGG Telomere Length Assay kit (Roche) as previously described
[43]. X-ray images were scanned on a ﬂat-bed scanner and analyzed
using MacBas V2.5 or MultiGauge V3.X (Fuji, Tokyo, Japan). Mean TRF
lengths were determined according to the following formula: [(Si/
Li)]/[Si], where Si is TRF signal at a given location after background
subtraction and Li is the corresponding length at position i. Repeated
measure of the mean telomere length of the BMhTERT(2A10) cell line
at a single time point in three individual TRF assays demonstrated
reproducibility within 300 bp. Telomere length of all samples was
measured on at least two gels.
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The MND and MND-hTR retroviral vectors were kindly provided
by Prof Joachim Lingner (ISREC-Swiss Institute for Experimental
Cancer Research, Lausanne, Switzerland). MND-hTR expresses hTR
from the U1 promoter downstream from a cDNA encoding neomycin
resistance, which was driven by the retroviral long-terminal repeat
[44]. The MND control vector carries the neomycin resistance gene
alone. Retroviral vectors encoding wild-type TRF1 (WT-TRF1) or
dominant-negative TRF1 (DN-TRF1) plus the puromycin resistance
gene and an “empty” vector, encoding puromycin resistance gene
alone (EV), were generously provided by Prof Titia de Lange
(Rockefeller University, New York, NY). Phoenix A packaging cells,
provided by Prof Garry Nolan (Stanford University, Palo Alto, CA),
were used for retroviral infections using our previously described
procedure [12]. The retroviral-infected cells were selected in medium
containing 800 μg/mL G418 (Invitrogen) or 0.8 μg/mL puromycin
(Sigma), as appropriate.
2.5. Real-time RT–PCR (qRT–PCR) analysis of gene expression
RNA was extracted using Trizol reagent (Invitrogen) according to
the manufacturer's protocol. Synthesis of cDNA was performed using
1 μg of RNA and Superscript II reverse transcriptase (Invitrogen). Each
real-time PCR included 12.5 μL of iQ SYBR Green Supermix (BioRad,
Hercules, CA), 10 μM each primer (Sigma), 100 ng of cDNA and
DNase- and RNase-free H2O to 25 μL. Primer sequences were as
follows: hTR forward 5′-CGCTGTTTTTCTCGCTGACTT-3′, hTR reverse
5′-TGCTCTAGAATGAACGGTGGAA-3′, hTERT forward: 5′-TGACACCT-
CACCTCACCCAC-3′, hTERT reverse: 5′-CACTGTCTTCCGCAAGTTCAC-3′,
β2-microglobulin forward 5′-CTCGCGCTACTCTCTCTTTCTG-3′ and β2-
microglobulin reverse 5′-TACATGTCTCGATCCCACTTAACTAT-3′. Cy-
cling conditions for hTR cDNA ampliﬁcation were as follows: 95 °C for
10 min, followed by 40 cycles of 95 °C for 30 sec, 64 °C for 30 sec, and
72 °C for 30 sec, then ﬁnally 1 min at 94 °C and 1 min at 60 °C. PCR
conditions for hTERT were 94 °C for 10 min, followed by 40 cycles of
95 °C for 15 sec, 65 °C for 1 min, and 72 °C for 30 sec, then ﬁnally
10 min at 72 °C. Gene expressionwas calculated from duplicates using
β2-microglobulin for normalization and the δδCT method. Values are
expressed as means±SEM derived from three experiments.
2.6. Quantitative telomeric repeat ampliﬁcation protocol (Q-TRAP)
Telomerase activity was measured by the quantitative real-time
PCR-based telomeric repeat ampliﬁcation protocol (Q-TRAP) method
using the Quantitative Telomerase Detection Kit according to the
manufacturer's instructions (Applied Biotech, Ijamsville, MD). Brieﬂy,
2–5×105 cells were lysed on ice in 1× lysis buffer for 30 min.
Dilutions of lysate from the SK-N-SH neuroblastoma cell line were
used to generate a standard curve. A master mix containing 1× QTD
Premix was dispensed into 96-well PCR plates, then 1 μL of lysate
(10 ng/μL) from each sample was added to duplicate wells to give a
ﬁnal volume of 25 μL. Heat-treated (85 °C for 10 min) SK-N-SH lysate
was included as a negative control. Real-time PCRswere performed on
an Applied Biosystems Real-time 7500 machine (Applied Biosystems,
Foster City, CA), which was programmed according to the manufac-
turer's protocol. Telomerase activity was measured in relation to a
standard curve generated using SK-N-SH and applying the software
accompanying the real-time PCR machine. Values are provided as
means±SEM calculated from duplicates in three independent
experiments.
3. Immunoblot
Protein lysates were prepared, and immunoblot analysis was
performed as previously described [43]. Brieﬂy, 25 μg of protein wasseparated by SDS–PAGE and transferred to polyvinylidine ﬂuoride
membrane (Millipore, Bedford, kMA). Membranes were stained with
0.1% (wt./vol.) Ponceau S (Sigma) in 5% aqueous acetic acid to conﬁrm
even transfer of proteins and then destained using Milli-Q water.
Membranes were blocked in 5% skim milk in Tris-buffered saline
(TBS) containing 0.05% Tween-20 (TTBS) for 1 hour at room
temperature (RT) and then hybridized to the following primary
antibodies: mouse anti-human p21cip1 monoclonal antibody (BD
Biosciences), rabbit anti-human p16INK4a polyclonal antibody (BD
Biosciences), mouse anti-human p53 monoclonal antibody (Santa
Cruz, Santa Cruz CA), M2 FLAG (Sigma), TRF1 (kindly provided by Prof
Titia de Lange, Rockefeller University, New York NY and Prof Roger
Reddel, Children's Medical Research Institute, Westmead Australia),
or rabbit anti-human actin (Sigma). Membranes were washed in TTBS
and hybridized to anti-rabbit or anti-mouse horseradish peroxidase-
conjugated secondary antibodies (AmershamBiosciences, Piscataway,
NJ) for 1 hour at RT. SuperSignal West Femto Chemiluminescent
substrate (Pierce, Rockford, IL) was used for detection of proteins,
which were imaged on Super HR-G 30 autoradiography ﬁlm (Fuji).
4. Results
4.1. Culture of hTERT-transduced BMECs under low OS conditions
Standard cell culture conditions in atmospheric oxygen (21% O2) are
mildly hyperoxic relative to in vivo conditions in healthy tissues, where
the partial oxygen tension is estimated to be 1%–6% [45]. To investigate
the effects of OS on telomerase-mediated telomere lengthmaintenance
in BMECs overexpressing hTERT, we compared telomere dynamics in
ECsgrownunder standard conditionswith cells grownunder conditions
that better approximate normal physiological conditions in vivo.
BMhTERT-2 cells were retrieved from cryogenic storage at 29.4 PD,
which was 21 PD posttransduction with hTERT. The cells were
expanded under standard culture conditions to 34.2 PD, then were
split four ways, with one ﬂask each maintained either (i) under control
conditions, (ii) in medium supplemented with the free radical
scavenger tBN at atmospheric (21%) oxygen (condition referred to as
tBN), (iii) in standardmediumat 5% oxygen (lowO2), or (iv) inmedium
supplemented with tBN and grown in 5% oxygen (tBN/low O2). To
conﬁrm that culturing the cells in tBN and low O2 decreased OS,
intracellular reactive oxygen species (ROS) in BMhTERT-2 cells were
measured using DHR123. DHR123 becomes highly ﬂuorescent when
oxidized by either H2O2 or superoxide. Flow cytometric analysis of
DHR123-stained cells conﬁrmed that the levels of intracellular ROSwere
signiﬁcantly lower in BMhTERT-2 cultured in tBN, lowO2, or tBN/lowO2
than in cells cultured in control conditions, with the lowest ROS
detected in cells in tBN/lowO2 (Fig. 1A). During long-termpropagation,
BMhTERT-2 cells grown in control, tBN or lowO2 conditions underwent
a growth lag (crisis) at ~45 PD that lasted for approximately 40 days
(Fig. 1B). In contrast to those cultures, BMhTERT-2 cells propagated in
tBN/low O2 maintained a consistent growth rate throughout the time
course. These results demonstrate that alleviationof chronic exposure to
mild hyperoxia, which occurs under standard culture conditions,
facilitates immortalization of BMhTERT cells.
4.2. Effect of culture under low OS conditions on telomere
length maintenance
Our previous investigations, and those of others, have shown that
retroviral overexpression of hTERT did not prevent net telomere loss
in human ECs grown under standard culture conditions [12,26]. The
mean telomere length of BMhTERT-2 cells grown under the alternate
conditions was compared by Southern blot-based TRF analysis
(Fig. 1C). TRF analyses over three time points conﬁrmed that there
was considerable telomere loss in BMhTERT-2 cells grown under
control conditions, such that the mean telomere length shortened by
Fig. 1. Low OS conditions promote immortalization and decrease the rate of telomere loss in BMhTERT-2 cells. (A) Intracellular ROS were assessed in BMhTERT-2 cells cultured in
control, tBN, low O2, and tBN/low O2 conditions using the ﬂuorescent dye DHR123. All cultures were at 40–41 PD at the time of the analysis. Values are expressed as means±SEM
calculated from three experiments. *pb0.05, **p b 0.01 using a repeated-measures ANOVA with Dunnett's multiple comparisons test with early passage cells in control conditions.
(B) Proliferation of BMhTERT-2 cells in control, tBN, low O2; and tBN/low O2 culture conditions. PDs were calculated from the day of BMEC isolation. (C) Telomere length was
measured by TRF analysis of BMhTERT-2 cells at multiple time points. PD and culture conditions are indicated above the blot. Molecular weightmarkers in kilobasepairs are shown to
the left of the blot and the white bars indicate mean telomere length. Telomere loss is summarized in the graph to the right of the blot.
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PD). The overall rate of telomere shortening over this period was less
in BMhTERT-2 cells grown under the lower OS conditions, with an
overall reduction in mean telomere length of 3.0 kbp/56 PD (53.6 bp/
PD), 2.7 kbp/54 PD (50.0 bp/PD), and 2.2 kbp over 53.7 PD (41.1 bp/
PD) in cells grown in tBN, low O2, and tBN/low O2 conditions,
respectively.
4.3. Culture under low OS conditions enhances telomerase enzyme
activity and hTR expression
We next investigated the effect of modulating exposure to OS on
the level of telomerase enzyme activity in BMhTERT-2 cells using the
Q-TRAP method. The level of telomerase activity detected in
BMhTERT-2 cells cultured under control conditions was comparable
to that detected in HeLa tumor cells and was stable in BMhTERT-2
cells from early-passage (40 PD) to a late-passage time point (100 PD)
(Fig. 2A). However, the level of telomerase activity was signiﬁcantly
higher in early-passage cells that were propagated under low OS
conditions for approximately 6 PD. The most substantial effect was
observed in early-passage cells cultured in tBN/low O2, where
telomerase activity was approximately eight-fold higher compared
with control cells (pb0.001). Telomerase activity was also signiﬁ-
cantly higher in late-passage cells cultured in tBN and tBN/low O2 in
comparisonwith cells passaged under control conditions (pb0.05 and
pb0.001, respectively). However, telomerase activity in cells grown in
the low O2 conditions returned to basal levels at the late passage timepoint. Thus, in short-term culture, telomerase activity was enhanced
by each of the three low OS conditions. This effect was partially
maintained until late passage in cells grown in tBN and tBN/low O2
conditions.
It seemed unlikely that the higher levels of telomerase enzyme
activity detected in early-passage BMhTERT cells grown in the lower
OS conditions were due to increased hTERT expression, since hTERT
was overexpressed from a retroviral promoter. This was conﬁrmed by
qRT–PCR analysis, which showed that expression of hTERT was at
least 42-fold greater in BMhTERT-2 cells than in the SK-N-SH
neuroblastoma cell line and was not increased by the lower OS
conditions (Supplementary Fig. 1). Indeed, hTERTmRNAwas lower in
the cells immortalized in low O2 and tBN/lowO2 conditions compared
with the immortalized cells maintained under control conditions. We
therefore next investigated the expression of hTR. qRT–PCR analysis of
hTR gene expression showed that there was no signiﬁcant difference
in hTR expression in early passage versus late passage in BMhTERT-2
cells grown under control conditions (Fig. 2B). This result is consistent
with the stable expression of telomerase enzyme activity over this
time period (Fig. 2A). Also consistent with the pattern of telomerase
enzyme activity, there was a trend for higher levels of hTR expression
in early-passage BMhTERT-2 cells cultured in the three low OS
conditions, with signiﬁcantly higher levels (2.4-fold) detected in the
early-passage cells cultured in tBN (pb0.01) and tBN/low O2
(pb0.001). A modest elevation in hTR expression in late-passage
cells cultured in tBN or tBN/low O2 conditions also paralleled the
modulation of telomerase activity. Linear regression analysis
Fig. 2. Enhanced expression of telomerase enzyme activity and hTR under low OS
conditions. (A) Telomerase activity in early- (40 PD) and late-passage (90–100 PD)
BMhTERT-2 cells was quantiﬁed using the real-time PCR-based Q-TRAP assay. Values
were normalized to telomerase activity in SK-N-SH cell lysates. (B) Expression of hTR
was quantiﬁed by qRT–PCR analysis of early- and late-passage BMhTERT-2 cells grown
under alternate OS conditions. Values were normalized to hTR expression in normal
human ﬁbroblasts (MRC5 cells). Quantitations of telomerase activity and hTR
expression are means±SEM determined from duplicates in three independent
experiments. *pb0.05, **p b 0.01, ***p b 0.001 in two-way ANOVA with Bonferroni
posttest comparison with PD-matched cells in control condition. (C) Regression
analysis of hTR expression and telomerase activity in early- and late-passage BMhTERT-2
cells using mean values from data shown in A and B of this ﬁgure. AU indicates arbitrary
units.
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telomerase activity in BMhTERT-2 cells at these two time points in the
alternate conditions (p=0.01; Fig. 2C). These results suggest that
increased levels of hTR may underlie the elevation of telomerase
enzyme activity detected in early-passage BMhTERT cells cultured
under low OS conditions.
4.4. Low OS conditions enhance telomerase activity and reduce telomere
erosion in BMhTERT(2A2) cells
To conﬁrm the effects on telomere length observed in the
BMhTERT-2 cell line, the BMhTERT(2A2) cell line was also cultured
under the alternate OS conditions (Fig. 3). BMhTERT(2A2) was
derived by clonal dilution of an independently transduced BMhTERT
mass culture (BMhTERT-1) [41]. Culture in either tBN or tBN/low O2
promoted proliferation of this cell line through the crisis period
(Fig. 3A). Each of the three low OS conditionswasmore favorable thanthe control condition for telomere length maintenance (Fig. 3B). TRF
analysis demonstrated that the mean telomere length of BMhTERT
(2A2) cells in control conditions shortened by 1.0 kbp over 35 PD
(30.3 bp/PD). However, culturing BMhTERT(2A2) cells under low OS
conditions prevented measurable telomere shortening. Indeed, there
was an increase in the mean telomere length of BMhTERT(2A2) cells
grown in tBN/low O2 (900 bp over 44 PD, or 20.5 bp/PD). These
results conﬁrm the observations made with the BMhTERT-2 cells,
indicating that culture under low OS conditions facilitates telomere
length maintenance in hTERT-transduced BMECs.
Telomerase activity in the BMhTERT(2A2) cells was also enhanced
by the low OS culture conditions, with a ﬁve-fold higher level evident
in early-passage cells grown in tBN/low O2 than in passage-matched
cells in control conditions (Fig. 3C; pb0.001). In addition, telomerase
activity was enhanced by more than two-fold in early-passage cells
grown in tBN alone and in the late-passage cells grown in either tBN
alone (pb0.01) or tBN/low O2 (pb0.01).
Overall, the results obtained from the BMhTERT-2 and BMhTERT
(2A2) cell lineswere consistent, both showing enhanced proliferation,
higher levels of telomerase activity, and a reduced rate of telomere
length shortening when grown under low OS conditions. The
combined effects of tBN with low O2 was most effective.
4.5. Expression of p16INK4a, p53, and p21cip1 in BMhTERT cells cultured
under alternate OS conditions
Others have shown that culture conditions and exposure to OS
variously impacts on the expression of the tumor suppressors
p16INK4a, p53, and p21cip1 in primary and hTERT-transduced ﬁbro-
blasts and epithelial cells [17,46,47]. Stress-induced activation of
these pathways may result in the selective outgrowth of cells that
have repressed tumor suppressor activity. Our previous study showed
that ~40% of BMhTERT clones repressed p16INK4a during immortali-
zation and that p53 deletion occurred as a rare event in 1 out of 12
clones [41].We investigated the expression of these tumor suppressor
proteins in BMhTERT cells cultured under alternate conditions by
immunoblotting. The results showed that expression of p16INK4a was
retained in all late-passage BMhTERT-2 and BMhTERT(2A2) cultures,
irrespective of the growth conditions (Figs. 4A and B). In the early-
passage BMhTERT-2 and BMhTERT(2A2) cells, growth in the tBN/low
O2 condition was associated with slightly lower levels of p53 and
p16INK4a expression, which is consistent with the expected effects of
alleviating stress. However, the ability of the cells to overcome crisis
was not associated with consistent effects on these tumor suppres-
sors, since BMhTERT(2A2) cells grown in tBN alone circumvented
crisis without apparent alteration in p53 and p16INK4a levels. Notably,
expression of p53 and p21cip1 was suppressed to very low/
undetectable levels in late-passage BMhTERT-2 cells grown in tBN/
low O2. This appeared to be due to a defect in the p53/p21cip1
pathway, since there was no induction of p53 or p21cip1 following
treatment with the DNA damage agent, etoposide (data not shown).
Overall, these data are consistent with our previously published
results, which showed that p53 loss occurred as an infrequent
spontaneous event during immortalization of BMhTERT cells [41].
4.6. OS overrides telomerase-mediated telomere lengthening that is
otherwise mediated by TRF1 inhibition
Previous studies have shown that telomerase-mediated telomere
lengthening is negatively regulated in tumor cells by the telomere
binding protein TRF1 [34,48]. We therefore tested whether TRF1
similarly impedes telomere lengthening in telomerase-positive ECs,
by retroviral vector-mediated overexpression of DN-TRF1 [34]. DN-
TRF1 lacks both the acidic domain at the carboxyl terminal, as well as
the Myb DNA binding domain at the amino terminal. It is thought to
exert a dominant-negative effect by dimerizing with endogenous
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of DN-TRF1 expression in immortalized BMECs, we tested vectors
encoding DN-TRF1 or full-length TRF1 (WT-TRF1) in the HT1080
ﬁbrosarcoma cell line. Immunoblot analyses conﬁrmed expression of
exogenous TRF1 proteins of the expected size in both the nucleus and
cytoplasm of stably transfected HT1080 cells (Supplementary Figs. 2A
and B) [34]. A protein of approximately 60 kDa, expressed in the WT-
TRF1-transduced cells, was detected only in the cytosol and wastherefore unlikely to contribute to telomere length regulation.
Southern blot-based TRF analysis of telomere length showed that
while the mean telomere length of WT-TRF1- and EV-transduced
HT1080 cells was maintained between 5.0 and 6.4 kbp, the mean
telomere length of DN-TRF1-transduced cells progressively increased
to 11.5 kbp over 70 PD, which corresponded to a lengthening rate of
75 bp/PD (Supplementary Figs. 2C and D). These data showed that
overexpression of DN-TRF1 resulted in very efﬁcient telomere
lengthening in HT1080 cells, conﬁrming the results of van Steensel
and de Lange [34].
The consequence of DN-TRF1 overexpression was then examined
in an immortalized BMhTERT cell line, BMhTERT(2A10) (Fig. 5). The
BMhTERT(2A10) cell line used in these investigations underwent a
crisis period (Supplementary Fig. 3) and exhibited dramatic ﬂuctua-
tions in telomere length during immortalization. This clone exhibited
telomere loss down to a mean length of 2.1 kbp at 56 to 64 PD, then
extension to a mean length of 6.6–6.7 kbp, which was maintained
from 92 to 117 PD ([41] and additional data not shown). Similar mean
telomere length ﬂuctuations were observed during immortalization
of other BMhTERT clones [41]. BMhTERT(2A10) cells were infected
with vectors encoding TRF1 cDNAs or the EV at 116 PD. Following
selection in puromycin, exogenous gene expression was conﬁrmed by
immunoblot analyses (Fig. 5A). The transduced cells were cultured
under control conditions or in the tBN/low O2 condition. TRF analysis
of the cells cultured under control conditions showed that the mean
telomere length of the EV cells ﬂuctuated between 4.0 and 8.0 kbp
over 40 PD posttransduction and thatWT-TRF1-transduced cells were
subjected to dramatic telomere loss (3.1 kbp decrease in mean
telomere length over 59 PD; Fig. 5B). However, in contrast to the
dramatic telomere lengthening observed in DN-TRF1-transduced
HT1080 cells, the mean telomere length of BMhTERT(2A10) cells
overexpressing DN-TRF1 did not increase under control culture
conditions. Indeed, under these conditions, there were periods of
considerable telomere loss (Fig. 5B).
Telomere length dynamics in EV, WT- and DN-TRF1-transduced
BMhTERT(2A10) cells were substantially altered by growth in tBN/
low O2. While the EV-transduced BMhTERT(2A10) cell line propagat-
ed under control culture conditions exhibited extensive telomere
length ﬂuctuations, the mean telomere length of these cells was
relatively stable when they were grown in tBN/low O2 (Fig. 5C).
Telomere length was also more stable in WT-TRF1-overexpressing
cells when grown in tBN/low O2 (Fig. 5C). Furthermore, substantial
telomere lengthening was observed in DN-TRF1-transduced cells
cultured in tBN/low O2 (2 kbp over 37 PD; Fig. 5C).
The relationship between telomere lengthen dynamics and
telomerase activity in TRF1-transduced BMhTERT(2A10) cells was
investigated using the Q-TRAP assay. The results showed that
transduction with WT-TRF1 or DN-TRF1 had no effect on the level
of telomerase activity, which is consistent with previous studies of
tumor cell lines [34]. However, consistent with the results obtained
with the BMhTERT-2 and BMhTERT(2A2) cells (Figs. 2 and 3),
telomerase activity in BMhTERT(2A10) cells was enhanced by more
than two-fold in cells cultured in tBN/low O2 for approximately 20 PDFig. 3. Low OS conditions promote immortalization, decrease the rate of telomere loss,
and enhance telomerase activity in BMhTERT(2A2) cells. (A) Proliferation of BMhTERT
(2A2) cells in control, tBN, low O2, and tBN/low O2 culture conditions. PDs were
calculated from the day of BMEC isolation. (B) Telomere length was measured by TRF
analysis at early and late passage. PD and culture conditions are indicated above the
blot. Molecular weight markers in kilobasepairs are shown to the left of the blot, and the
white bars indicate mean telomere length. The ﬁgure is representative of three
independent TRF blots. Telomere length as a function of PD is summarized in the graph
below the blot. (C) Telomerase activity in early- (66 PD) and late-passage (100 PD)
BMhTERT(2A2) cells was quantiﬁed using the Q-TRAP assay. Values were normalized to
telomerase activity in SK-N-SH cell line and expressed as means±SEM determined
from duplicates in three independent experiments. **pb0.01, ***p b 0.001 in two-way
ANOVA with Bonferroni posttest comparison with PD-matched cells in control
condition.
Fig. 4. Expression of p53, p21cip1, and p16INK4a in BMhTERT cells with varied exposure to OS. Immunoblots showing expression of p53, p21cip1, and p16INK4a expression in (A)
BMhTERT-2 and (B) BMhTERT(2A2) cultures at early and late passage when grown in control, tBN, low O2, or tBN/low O2 conditions. The antibodies used are indicated at the left of
each blot. PD and culture conditions are above each lane. HeLa, MCF-7, and MOLT-4 were used as positive controls.
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activity detected in the tBN/low O2-cultured cells (Fig. 5E). Overall,
these results conﬁrm that TRF1 negatively regulates telomere length
in hTERT-immortalized BMECs. However, they also highlight the
deleterious impact of OS on telomerase-mediated telomere length-
ening in these cells.4.7. Overexpressionof hTRenables telomere lengthening in BMhTERT-2 cells
The results showing that hTR levels correlated with telomerase
activity (Figs. 2B and C and 5D and E) suggested that hTR levels limit
telomerase activity in cells cultured under standard culture condi-
tions. We therefore directly tested the effect of hTR levels on
telomerase enzyme activity by overexpressing hTR in BMhTERT-2
cells. BMhTERT-2 cells were transduced either with a retroviral
vector carrying an hTR transgene and the neomycin resistance gene
(MND-hTR) or a control vector encoding neomycin resistance only
(MND) at 33 PD [44]. Following selection in G418, the cells were split
into either control conditions or tBN/low O2 and cultured until
~100 PD. There was no apparent difference in the proliferation of
MND-hTR and MND-transduced cells (data not shown). qRT–PCR
analysis showed total hTR expressionwas dramatically higher in cells
transduced with MND-hTR relative to control vector-transduced
cells at the earliest time point assayed (~44 PD; Fig. 6A). Moreover,
Q-TRAP analysis revealed an approximately 10-fold increase in
telomerase activity in MND-hTR cells relative to MND cells at this
time point (~44 PD; Fig. 6B). As an apparent consequence of the high
levels of hTR and telomerase activity, MND-hTR cells underwent
dramatic telomere lengthening shortly after transduction (Fig. 6C).
Together, the results indicate that expression of hTRwas rate limiting
for high levels of telomerase activity and restricted telomere
lengthening in hTERT-transduced BMECs.
hTR declined in MND-hTR cells propagated under standard culture
conditions, to the extent that levels werewithin the basal range by the
time the cells reached 88 PD. hTR levels also decreased in MND-hTR
cells cultured in tBN/low O2; however, they remained above basal
levels at the 88 PD time point (Fig. 6A). The decrease in hTR was
conﬁrmed to be due to silencing of the transgene, since vector-speciﬁc
qRT–PCR showed decreasing transgene expression (data not shown),
while PCR of gDNA showed that the vector remained integrated in the
infected cells throughout the time course (Supplementary Fig. 4).
Consistent with the decline in hTR transgene expression, telomeraseactivity in MND-hTR-transduced cell was also lower at the late-
passage time point. Consequently, in cells cultured under standard
conditions, the initial increase in mean telomere length was followed
by a period of shortening (64–82 PD). MND-hTR-transduced cells
grown in tBN/low O2 exhibited dramatic and sustained telomere
lengthening, which was consistent with the persistence of a higher
level of telomerase activity in these cells (Figs. 6A and B).
Endogenous hTR expression and total cellular telomerase activity
were higher in MND cells propagated in tBN/low O2, compared with
the same cells cultured under control conditions (Figs. 6A and B).
Telomere length measurements showed that MND cells were subject
to net telomere shortening (3.2 kbp/70 PD or 46 bp/PD) under
control conditions, while telomere length was maintained when the
cells were cultured in tBN/low O2 (Fig. 6C). These results corroborate
data from the nontransduced BMhTERT-2 cells, which showed higher
hTR, enhanced telomerase activity and stabilization of telomere
length under low OS conditions (Figs. 1C and 2A and B). Overall, the
data demonstrate that telomere length maintenance was compro-
mised in BMhTERT-2 cells cultured under standard conditions as a
consequence of inadequate levels of hTR and low telomerase activity,
which resulted from chronic exposure to mild hyperoxia.5. Discussion
In comparison to ﬁbroblasts and other cell types, ECs expressing
hTERT are relatively inefﬁcient at telomere length maintenance when
grown under standard tissue culture conditions [12,26,39,40]. The
current report demonstrates that this is largely a consequence of
chronic low-level OS inﬂicted by in vitro propagation in ambient
oxygen and standard culture medium. Since physiologically normal
oxygen tension is estimated to be 1%–6% in vivo, control culture
conditions (21% O2) represent a mildly hyperoxic condition, as may
occur in certain pathologic states.
While it is well established that ROS directly target and damage
telomeric DNA [23], past reports also show that acute OS may
compromise telomere length maintenance in ECs by dampening
telomerase enzyme activity [15,21,49,50]. Consistent with those
studies, a subtle enhancement of total cellular telomerase activity
was demonstrated when ECs derived from a subgroup of atheroscle-
rosis patients were cultured in the antioxidant N-acetylcysteine
(NAC) [51]. Our results showing that alleviation of OS by culture in a
free radical scavenger and lower oxygen tension enhanced telomerase
Fig. 5. Effect of TRF1 inhibition on telomerase-mediated telomere lengthening in BMECs grown in control or tBN/low O2 conditions. (A) A representative Western blot of
BMhTERT(2A10) cells transducedwith retroviral vectors encodingWT-TRF1, DN-TRF1, or control EV and cultured under standard or tBN/lowO2 conditions. The antibody used to
probe each blot is indicated to the left of the panel. PD at the time of analysis, indicated above each lane, was calculated from the time of the retroviral transduction. (B and C)
Representative TRF analyses of BMhTERT(2A10) cells at multiple time points when grown in (B) control or (C) tBN/low O2 conditions. PD since retroviral transduction is shown
above each lane. Mean telomere lengths are indicated by thewhite bars. Changes inmean telomere length since transduction are summarized in the graph at the right of each TRF
blot. Data in the graphswere derived from at least two TRF gels for each cell line and therefore include some points not shown on the blots. (D) Telomerase activity was quantiﬁed
using the Q-TRAP assay. Values were calculated relative to SK-N-SH lysate. (E) hTR expression was analyzed by qRT–PCR. Values for telomerase activity and hTR expression are
means±SEM determined from duplicates in three independent experiments. **pb0.01, ***p b 0.001 in two-way ANOVA with Bonferroni posttest comparison with PD-matched
cells in control condition.
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Fig. 6. Overexpression of hTR enhances telomerase activity and promotes telomere lengthening in BMhTERT-2 cells. BMhTERT-2 cells were transduced with MND-hTR or the control
vector MND. (A) Expression of hTR was assessed by qRT–PCR and was normalized to hTR in normal human ﬁbroblasts (MRC5 cells). (B) Telomerase activity was assessed by the Q-
TRAP assay at early and late passage time points. The values indicate telomerase activity relative to the SK-N-SH neuroblastoma cell line. Telomerase activity and hTR values are
expressed as means±SEM of three experiments. AU indicates arbitrary units. (C) Telomere length was measured by TRF analysis of BMhTERT-2 cells transduced with MND and
MND-hTR. N indicates the starting population of nontransduced cells. Culture conditions and PD at the time of the assay are indicated above the blot. Molecular weight markers in
kilobasepairs are shown at the left of the blot, and the white bars indicate mean telomere length. Telomere ﬂuctuations are summarized in the graph to the right of the blot.
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however, the current report also shows that chronic low-level OS
impeded telomerase enzyme activity and telomere length mainte-
nance despite constitutive expression of hTERT mRNA at levels that
were 42-fold higher than those detected in immortal tumor cells.
Furthermore, our data indicate that telomerase activity in hTERT-
transduced BMECs was restricted by the amount of hTR present and
that hTR levels were suppressed by hyperoxia resulting from
propagation in ambient oxygen.
The correlation between telomerase enzyme activity and hTR
levels in BMhTERT cells grownunder variousOS conditions, implicated
hTR as a “rate-limiting” determinant of telomerase activity. The direct
impact of hTR levels on telomerase enzyme activity was then
demonstrated by experiments that showed hTR overexpression
increased telomerase activity to a level thatwas sufﬁcient for telomere
lengthening. These data add to recent studies that have shown
increased expression of hTR enhances telomerase enzyme activity in
other cellular contexts [44,52]. The apparent sensitivity of hTR to
chronic mild hyperoxia warrants consideration in relation to theproposed use of telomerized ECs for tissue engineering applications in
disorders where OS may be a contributing factor [4,7,21,35,36,53].
Coexpression of both hTERT and hTR may be required for reconstitu-
tion of sufﬁcient telomerase activity to stabilize telomere length under
those conditions. It will be important for future studies to determine
whether mild hyperoxia has similar effects on hTR and telomerase
activity in endothelial progenitors or hTERT-transduced ECs derived
from alternate anatomical sites, such as the aorta.
The mechanisms that link OS to alterations in hTR levels remain to
be determined. Posttranscriptional stabilization of hTR through direct
binding with dyskerin is a well-described aspect of hTR regulation.
However, dyskerin mRNA and protein levels did not correspond with
hTR levels or telomerase activity in BMhTERT-2 cells cultured under
alternate OS conditions (additional data not shown). Transcription of
the gene-encoding hTR is regulated by the ubiquitous factors sp1 and
sp3 [54]. Notably, the JNK signaling pathway, which is activated by
ROS and other types of stress, was shown to repress hTR transcription
via these transcription factors [55]. It is also noteworthy that hTR
levels were transiently elevated in ovarian tumor cells deprived of
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transcriptional activity of the hTR promoter under those condi-
tions [56]. These signaling pathways warrant investigation as
potential mediators of hTR regulation in human ECs.
A previous study showed that exposure to a high level of OS
(40% O2) had no effect on total cellular telomerase enzyme activity
in hTERT-transduced ﬁbroblasts [57]. Since other studies had shown
that OS dampens endogenous telomerase activity in tumor cells, it
was proposed that the lack of effect observed in hTERT-transduced
ﬁbroblasts indicated that oxidants principally regulate telomerase
through modulation of hTERT transcription [58]. Evidence of OS-
induced transcriptional modulation of hTERT was provided by a
recent study that showed a HIF-1α-dependent mechanism was
responsible for increased endogenous hTERT mRNA and telomerase
activity in primary human ﬁbroblasts cultured in 1.5% O2 [59].
However, in that study, the activation of HIF-1α and up-regulation of
hTERT mRNA in 1.5% O2 were associated with higher levels of
mitochondrial ROS. This contrasts with lower levels of total cellular
ROS detected in BMhTERT-2 cells cultured in 5% O2 with or without
tBN. Our results do not rule out the possibility that mild hyperoxia
may affect endogenous telomerase enzyme activity by altering the
expression of hTERT. However, they are the ﬁrst to demonstrate the
susceptibility of hTR to OS and to provide evidence that hTR levels
limit telomerase enzyme activity and telomere length in ECs exposed
to mild hyperoxia. It will be of interest for future investigations to
further unravel the mechanisms that underpin redox-dependent
transcription of both hTR and hTERT in a variety of cell types exposed
to different levels of OS.
In addition to the transcriptional control of telomerase compo-
nents, other studies performed with hTERT-overexpressing ﬁbro-
blasts and HEK293 tumor cells suggest that high levels of OS
impedes telomerase-mediated telomere maintenance via a mecha-
nism that involves export of hTERT from the nucleus to the
mitochondria [60,61]. While this mechanism remains to be explored
in hTERT-transduced ECs, it seems unlikely to have contributed to
the telomere length impediment observed in BMhTERT cells
cultured under standard conditions, since hTERT was shown to be
entirely localized within the nucleus in other cell types cultured
under standard conditions and was transported to the mitochondria
only under very high OS conditions (40% O2 or 500 μM hydrogen
peroxide) [60,61].
Culture in tBN and 2%–5% O2 was previously shown to be favorable
for the immortalization of hTERT-transduced ﬁbroblasts [17]. The
current report demonstrates the effects of this approach on
proliferation of BMECs overexpressing hTERT. Our data show that
propagation under low OS conditions enabled BMhTERT cells to
proliferate through a ‘crisis’ period. Our previous analysis of a panel of
BMhTERT clones indicated that the onset of crisis was unrelated to
telomere length [41]. Results from the current study, which shows no
apparent relationship between telomere length and the propensity for
BMhTERT(2A2) cells cultured in tBN and tBN/low O2, but not low O2,
to subvert crisis, concurs with those ﬁndings. The proliferative
advantage of cells cultured under low OS conditions was most likely
mediated by a telomere length-independent mechanism. Since tBN
acts directly on mitochondria to prevent ROS-induced toxicity, it is
possible that the tBN and tBN/low O2 conditions promoted prolifer-
ation of BMhTERT(2A2) cells through crisis by protecting mitochon-
dria from accumulation of age-associated damage [42]. However,
there appeared to be clonal variations in sensitivity of precrisis
BMhTERT cells to OS, as tBN alone was not sufﬁcient for BMhTERT-2
cells to proliferate through crisis. Only BMhTERT-2 cells grown in the
combination of tBN and low O2 exhibited a proliferative advantage
during the crisis period. Consistent with our data, a report published
online while the current paper was under revision indicated that N-
acetylcysteine (NAC) facilitated immortalization of hTERT-transduced
mammary arterial endothelial cells [62]. While the proliferation ofhTERT-transduced ECs grown in the absence of NAC was not shown in
that study, it was apparent that only a subset of hTERT-transduced
cultures grown in NAC was immortalized.
The onset of crisis and subsequent immortalization of BMhTERT
cells was not simply explained by the pattern of p16INK4a expression.
This was evident from the analysis of BMhTERT(2A2) cells cultured in
tBN alone. These cells escaped crisis although they expressed p16INK4a
at levels similar to control cells that underwent crisis. Furthermore, all
immortalized BMhTERT-2 and BMhTERT(2A2) cells continued to
express p16INK4a irrespective of growth conditions andwhether or not
they went through crisis. Overall, the data are consistent with our
previous study, which showed that neither repression of p16INK4a nor
inactivation of p53 was necessary for immortalization of BMhTERT
cells [41].
The other aspect of telomerase-mediated telomere length
regulation that was investigated in this study was the role of TRF1.
In contrast to previous studies of immortal tumor cells [34],
inhibition of TRF1 function by overexpression of DN-TRF1 did not
mediate telomere lengthening in immortal BMhTERT(2A10) cells
cultured under standard conditions. This appeared to be due to
limited hTR expression, as propagation of in DN-TRF1 BMhTERT
(2A10) cells in tBN/low O2 increased hTR levels, enhanced
telomerase enzyme activity, and enabled considerable telomere
elongation. Notably, steady and progressive telomere lengthening
occurred exclusively in DN-TRF1-transduced cells and not in cells
transduced with WT-TRF1 or with a control vector. These results not
only conﬁrm that TRF1 functions as a negative regulator of
telomerase-mediated telomere length maintenance in immortal
BMECs, but also reiterate the effects of OS on telomerase and
telomere length in these cells.
In summary, this report provides new insight to the effects of mild
hyperoxia on telomerase-mediated telomere length maintenance in
human ECs. Chronic exposure to mild hyperoxia, as occurs under
standard culture conditions, was shown to dampen telomerase
activity and impede telomere length maintenance in BMECs despite
constitutive overexpression of hTERT and inhibition of TRF1 function.
The apparent deﬁciency in telomerase-mediated telomere length
maintenance in BMhTERT cells appeared to be due to limiting
amounts of hTR resulting from chronic exposure to 21% O2. These
results illustrate an overriding effect of OS on telomerase activity in
human ECs and have important implications in relation to the
potential use of telomerase activation in the treatment of disorders
involving EC dysfunction.Acknowledgements
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